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Abstract 
We here report on a case of metachronous multicentric carcinomas of the biliary tract 
treated 3 times with curative surgery over 23 years. A 28-year-old woman underwent 
cholecystectomy because of papillary carcinoma of the gallbladder. After 17 years, 3 
carcinomas developed in the biliary tract: intrahepatic cholangiocarcinoma of the left 
liver, common bile duct carcinoma, and remnant cystic duct carcinoma. They were 
successfully removed via left hepatectomy combined with pylorus-preserving 
pancreatoduodenectomy. Furthermore, another intrahepatic cholangiocarcinoma 
developed 6 years after the second surgery, which was removed again via partial 
resection of the posterior segment of the liver. Histological findings of carcinomas 
represented various grades of cell differentiation. No predisposition toward 
carcinogenesis was found, since neither pancreaticobiliary maljunction nor primary 
sclerosing cholangitis was present, and the overexpression of cyclooxygenase-2 was 
negative in all resected specimens. Close monitoring for recurrence is warranted for early 
detection of metachronous carcinoma that might be effectively treated with repeated 
resection. 
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Introduction 
Carcinoma of the biliary tract sometimes displays synchronous or metachronous 
multicentric origins. We present the case of a patient who underwent successful repeated 
tumor resections for 3 different kinds of metachronous carcinoma of the biliary tract. To 
clarify predispositions toward carcinogenesis in the biliary tract, immunohistochemical 
staining was applied to the resected specimens. 
Case Report 
A 28-year-old woman underwent cholecystectomy in March 1979 at our hospital due to carcinoma 
of the gallbladder that displayed diffuse spread without lymph node involvement. The stump of the 
cystic duct was histologically negative for cancer cells. Histology of the tumor was papillary carcinoma 
and the depth of the tumor was limited to the mucosal layer (fig. 1a, b). No family history of malignant 
neoplasms was present. 
The patient remained disease-free for 18 years after surgery, but was then hospitalized again due to 
epigastric pain. Laboratory data were all within normal ranges, except for serum CA19–9 at 90 IU/ml. A 
low density area measuring 5 × 4 cm was detected in the left hepatic lobe on computed tomography 
(CT) (fig. 2a). Furthermore, tumor shadows were observed in the common bile duct on endoscopic 
retrograde cholangiopancreatography. Neither pancreaticobiliary maljunction (PBM) nor primary 
sclerosing cholangitis (PSC) was present (fig. 2b). All tumors were successfully removed via left hepatic 
lobectomy combined with pylorus-preserving pancreatoduodenectomy in May 1997. Macroscopically, 
resected specimens displayed a variety of tumors, with a tumor arising from the remnant cystic duct and 
a tumor in the common bile duct identified as pedunculated polypoid tumor associated with widespread 
tiny granular lesions. Histology of the hepatic tumor was intrahepatic cholangiocarcinoma (ICC) that 
had invaded the ligamentum teres hepatis, associated with mucosal spread along the left hepatic duct, 
and represented poor cell differentiation, while pedunculated polypoid tumors were identified as 
papillary adenocarcinoma. Widespread tiny granular lesions represented severe dysplasia (fig. 3a–c). 
In November 2003, follow-up CT detected a minute but gradually enlarging low-density area in the 
posterior segment of the liver. The tumor was removed via partial resection of the liver in February 
2004. The resected tumor measured 2.1 × 1.9 cm and displayed intraductal spread forming a small 
tumor mass. Histology of the tumor was ICC that represented moderate cell differentiation (fig. 4a, b). 
The patient has remained disease-free for 4 years. 
Findings of histology and immunohistochemical staining for expression of p53 and cyclooxygenase-
2 (COX-2) protein are summarized in table 1. Some carcinomas showed negative p53 protein 
expression, but the other carcinomas were positive. COX-2 protein expression was negative in all cancer 
cells, non-cancerous biliary epithelial cells and mucosal dysplasia. 
Discussion 
The present case is extremely rare, as 3 different kinds of carcinoma developed 
metachronously over the course of 25 years. Long-time intervals between the onsets of the 
individual tumors substantially support the hypothesis that they are nonmetastatic 
tumors that developed independently. Additionally, they individually present different 
histology and cell differentiation. The exact mechanism of carcinogenesis in this patient 
remains unclear, since the patient displayed neither PBM nor PSC, both of which are 
widely accepted as strong risk factors for carcinoma of the biliary tract. Previous reports 
show that patients with PBM tend to have synchronous multicentric biliary carcinoma, 
and metachronous carcinoma sometimes develops even after resection of choledochal 
cyst associated with carcinoma [1–3]. 
To clarify the predisposition toward carcinogenesis in the biliary epithelium, 
immunohistochemical study was carried out. COX-2 expression has been confirmed to  
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promote carcinogenesis by producing prostaglandin E2 in an intestinal polyposis model 
[4, 5], and p53 mutations are involved in carcinogenesis in the biliary epithelium [6, 7]. 
However, COX-2 protein expression was not observed both in noncancerous biliary 
epithelial cells and cancer cells, and p53 dysfunction appears unrelated to the multicentric 
origins of carcinogenesis in this patient. The only interesting histological finding we could 
identify was the concurrence of widespread mucosal dysplasia in the common bile duct; a 
dysplasia-carcinoma sequence has been assumed as the main route of carcinogenesis, like 
the adenoma-carcinoma sequence in familial adenomatous polyposis and colon 
carcinoma. 
Thus the exact mechanism of carcinogenesis remains to be elucidated in this patient; 
however, many reports have offered clinical evidences of metachronous carcinoma which 
developed at the site of hepaticojejunostomy or at intrahepatic or terminal bile ducts a 
long time after the initial surgery [8]. Patients who have once experienced papillary 
carcinoma in the biliary tract might have a long-term risk of carcinogenesis. 
Morphologically, second tumors usually display a papillary type similar to the primary 
tumor, and the depth of tumor is superficial without tumor invasion to neighboring 
organs. Aggressive surgical approach to the treatment of such tumors is technically 
possible and a rational therapeutic option that offers a chance of long-time survival for 
patients. Close monitoring for recurrence is warranted for early detection of tumors that 
might be effectively treated with repeated resection. 
 
 
 
Table 1. Clinicohistopathological and immunohistochemical findings 
Year  Organ  Gross appearance/histological type  p53  COX2
1979  gallbladder  papillary carcinoma/papillotubular adenocarcinoma  +  – 
    noncancerous biliary mucosa/normal  –  – 
1997 liver  ICC/poorly  differentiated adenocarcinoma  +  – 
  cystic duct  papillary carcinoma/papillary adenocarcinoma  +  – 
  extrahepatic bile duct  papillary carcinoma/papillary adenocarcinoma  –  – 
    biliary mucosa with widespread tiny granular lesions/severe 
dysplasia 
 
– 
 
– 
    noncancerous biliary mucosa/normal  –  – 
2004  liver  ICC/moderately differentiated tubular adenocarcinoma  –  – 
    noncancerous biliary mucosa/normal  –  – 
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Fig. 1. a Microscopic findings of the small nodular lesion of the gallbladder. Epithelial cells 
proliferating with papillary and/or tubular pattern. H&E, ×10. b High-power view of the lesion shows 
nuclear atypia. Diagnosed as papillary carcinoma in situ. H&E, ×40. 
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Fig. 2. a Abdominal computed tomography shows a low-density mass (arrow) in the left hepatic lobe. 
b Endoscopic retrograde cholangiopancreatography demonstrates a tumor shadow (arrow) in the 
common bile duct. 
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Fig. 3. a Microscopic view of the hepatic tumor showing poorly differentiated tubular adenocarcinoma 
and irregular shaped small glands infiltrating in the fibrous interstitium. b Microscopic view of the 
cystic duct tumor. Polypoid lesion measuring 18 mm in diameter was histologically identified as 
papillary adenocarcinoma. c In the mucosa of the intra- and extrahepatic biliary tract, foci of small 
papillary projections of the epithelium with slight nuclear atypia were widely spread. 
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Fig. 4. a Cut surface of the resected liver at the third surgery showing a whitish, well-circumscribed 
tumor measuring 21 × 19 mm. b Histologically, moderately differentiated tubular adenocarcinoma 
with fused glands focally showed papillary growth pattern. H&E, ×10. 
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